Commodore Capital LP has filed 18 Form 4s with the SEC that we hold, for STSA (10% owner), Enliven Therapeutics, Inc. (ELVN) (10% owner), Vera Therapeutics, Inc. (VERA) (10% owner) and Vistagen Therapeutics, Inc. (VTGN) (10% owner). Across all of them we count 23 purchases worth $27.6M and 2 sales worth $21.2M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 1,050,000 shares of Vera Therapeutics, Inc. worth $18.9M, dated 2024-01-10. The first filing on our record is dated 2021-10-19 and the latest 2024-01-12.
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-10-15 | P, purchase reported on Form 4 | 126,000 | $608.6K | 2021-10-19 |
| 2021-10-18 | P, purchase reported on Form 4 | 36,194 | $176.3K | 2021-10-19 |
| 2021-10-19 | P, purchase reported on Form 4 | 87,580 | $444.0K | 2021-10-21 |
| 2021-10-20 | P, purchase reported on Form 4 | 40,663 | $221.2K | 2021-10-21 |
| 2021-10-21 | P, purchase reported on Form 4 | 32,816 | $177.2K | 2021-10-25 |
| 2021-10-22 | P, purchase reported on Form 4 | 27,629 | $152.2K | 2021-10-25 |
| 2021-10-27 | P, purchase reported on Form 4 | 39,581 | $215.7K | 2021-10-29 |
| 2021-10-28 | P, purchase reported on Form 4 | 15,082 | $83.7K | 2021-10-29 |
| 2021-10-29 | P, purchase reported on Form 4 | 44,651 | $255.0K | 2021-11-02 |
| 2021-11-02 | P, purchase reported on Form 4 | 8,880 | $50.1K | 2021-11-04 |
| 2021-11-04 | P, purchase reported on Form 4 | 1,400 | $8.2K | 2021-11-08 |
| 2021-11-05 | P, purchase reported on Form 4 | 7,800 | $46.4K | 2021-11-08 |
| 2021-11-08 | P, purchase reported on Form 4 | 560 | $3.4K | 2021-11-10 |
| 2021-11-10 | P, purchase reported on Form 4 | 9,622 | $56.3K | 2021-11-12 |
| 2021-11-11 | P, purchase reported on Form 4 | 7,941 | $48.0K | 2021-11-12 |
| 2021-11-19 | P, purchase reported on Form 4 | 3,225 | $17.5K | 2021-11-23 |
| 2021-11-22 | P, purchase reported on Form 4 | 9,979 | $54.8K | 2021-11-23 |
| 2021-11-24 | P, purchase reported on Form 4 | 2,922 | $15.8K | 2021-11-29 |
| 2022-11-14 | S, sale reported on Form 4 | 3,250,000 | $2.3M | 2022-11-16 |
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-02-21 | P, purchase reported on Form 4 | 8,194 | $43.0K | 2023-02-23 |
| 2023-02-22 | P, purchase reported on Form 4 | 23,565 | $120.4K | 2023-02-23 |
| 2023-02-23 | P, purchase reported on Form 4 | 622 | $13.7K | 2023-02-27 |
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-06-20 | P, purchase reported on Form 4 | 448,217 | $6.8M | 2023-06-22 |
| 2024-01-10 | S, sale reported on Form 4 | 1,050,000 | $18.9M | 2024-01-12 |
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-08-07 | P, purchase reported on Form 4 | 775,756 | $18.0M | 2023-08-09 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1831942) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms
No password to create and no card required. We store your email address and nothing else.